Prostate cancer overexpresses specific receptors, including gastrin-releasing peptide receptor (GRPR), prostate specific membrane antigen (PSMA), and integrins, etc. (Fig. 4a) [70]. This evidence concerns the gene FOLH1 and prostate carcinoma.